Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
HER2-positive or HER2-low metastatic Breast Cancer, HER2-mutant Non-Small Cell Lung Cancer, and Gastric Adenocarcinoma.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).
Adjuvant and metastatic treatment of postmenopausal women with Hormone Receptor-positive Breast Cancer.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Non-metastatic and metastatic Castration-Resistant and Castration-Sensitive Prostate Cancer.